Viewing nowCombinationZadiglyemmet Tablet 12.5/500 mg (Empagliflozin 2L-Proline, Metformin)
Empagliflozin 2L-Proline 18.9mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.

MFDS item code 202600010 · Approved 2026.01.05
Improvement of glycemic control in adults with type 2 diabetes
This medication is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are using empagliflozin and metformin together. It is particularly suitable for patients whose blood sugar is not adequately controlled, and should be administered under the guidance of a specialist in cases of concurrent cardiovascular disease. This medication effectively improves blood sugar levels and aids in overall diabetes management.
The recommended dose of this drug is 1 tablet twice daily. The dose should be determined based on each patient’s current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily dose of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who do not achieve adequate glycemic control with metformin alone or in combination with other medications such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) plus the patient’s existing metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this drug from treatment with empagliflozin (total daily dose 10 mg or 25 mg) in combination with metformin should receive the same existing doses of empagliflozin and metformin. When this drug is administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use 4. Adverse Reactions and 6. Interactions). This drug should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If a dose of this drug is missed, take it as soon as remembered. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dosage adjustment is necessary in patients with mild renal impairment. Because this drug contains metformin, it may be used with dosage adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual single-ingredient products of empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this drug is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use 3. Patients Requiring Cautious Administration, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this drug should be discontinued immediately (see Precautions for Use 2. Patients Who Must Not Take This Drug, item 2)). Elderly patients In patients 75 years of age or older, renal function and the risk of volume depletion should be considered.
This medication is used for the treatment of diabetes, acting with two components to help control blood sugar. While taking this medication, a rare side effect known as severe lactic acidosis may occur, with symptoms including malaise, muscle pain, difficulty breathing, and abdominal pain; immediate consultation with a physician is advised if these symptoms arise. Additionally, caution should be exercised as hypoglycemia may occur when taken with insulin or other diabetes medications, characterized by symptoms such as dizziness, cold sweats, and severe fatigue. Patients with poor kidney function, acute infection, dehydration, heart disease, or liver dysfunction should avoid using this medication. Especially before and after examinations that utilize iodinated contrast agents, this medication should be temporarily discontinued and resumed only after confirming normal kidney function. It is recommended that women who are pregnant or breastfeeding do not take this medication, and those planning pregnancy should consult with a physician. This medication may cause reduced fluid volume, so patients with a risk of dehydration or hypotension should use it with caution, and older adults should adjust the dosage while regularly monitoring kidney function. The risk of genital infections and urinary tract infections may increase during use, so any infection symptoms should be reported to healthcare personnel immediately. Vitamin B12 levels may decrease, so it is advisable to check through blood tests during long-term use. Overdosage can lead to serious side effects such as hypoglycemia or lactic acidosis, so adhering to the prescribed dosage is crucial, and if side effects are suspected, immediate medical attention should be sought. This medication's safety and efficacy have not been established in children, and it is recommended not to use it for those under 18 years of age.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. It is best to maintain a storage temperature between 1 to 30 degrees Celsius (room temperature). Proper storage will help maintain the medication's efficacy and safe use.
Light brownish-purple, convex, oval film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 2L-Proline 18.9mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 18.9mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 7.55mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 7.55mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 18.88mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Kyeongbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 7.55mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 18.88mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 18.88mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.